1. Beneficial and adverse effects of ketamine and its enantiomers, and the underlying mechanisms of ECT and rTMS efficacy

   • Kenji Hashimoto

   Editorial 12 April 2024 Pages: 755 - 757

2. Effects of melancholic features on positive and negative suicidal ideation in patients with treatment-resistant depression and strong suicidal ideation receiving low-dose ketamine infusion

   • Mu-Hong Chen
   • Tung-Ping Su
   • Pei-Chi Tu

   Original Paper 05 December 2023 Pages: 759 - 766

   

3. Risk of esketamine anesthesia on the emergence delirium in preschool children after minor surgery: a prospective observational clinical study

   • Sai Chen
   • Jin-Jin Yang
   • Jian-Jun Yang

   Original Paper 18 April 2023 Pages: 767 - 775

   

4. The atypical antidepressant tianeptine confers neuroprotection against oxygen–glucose deprivation

   • Burcu Ersoy
   • Marie-Louise Herzog
   • Karen Gertz

   Original Paper Open access 01 September 2023 Pages: 777 - 791

   

5. Cortical excitation/inhibition ratios in patients with major depression treated with electroconvulsive therapy: an EEG analysis

   • Sven Stuiver
   • Julia C. M. Pottkämper
   • Jeroen A. van Waarde

   Original Paper Open access 10 November 2023 Pages: 793 - 802

   

6. Transcranial alternating current stimulation in affecting cognitive impairment in psychiatric disorders: a review

   • Nina Biačková
   • Andrea Adamová
   • Monika Klírová

   Invited Review Open access 08 September 2023 Pages: 803 - 826

   

7. Influence of noninvasive brain stimulation on connectivity and local activation: a combined tDCS and fMRI study

   • Luise Victoria Claaß
   • Annika Hedrich
   • Jakob Kaminski

   Original Paper Open access 19 August 2023 Pages: 827 - 835

   

8. Relation between task-related activity modulation and cortical inhibitory function in schizophrenia and healthy controls: a TMS–EEG study

   • Inés Fernández-Linsenbarth
   • Gema Mijancos-Martínez
   • Vicente Molina

   Original Paper Open access 19 January 2024 Pages: 837 - 847

   

9. Changes in neuroactive steroids, neurotrophins and immunological biomarkers after monotherapy 8-week rTMS treatment and their relationship with neurocognitive functions in depression

   • Muhammed Emin Boylu
   • Şenol Turan
   • İsmet Kırpınar

   Original Paper 18 November 2023 Pages: 849 - 865

   

10. Optogenetic activation of the lateral habenula^D1R–ventral tegmental area circuit induces depression-like behavior in mice

    • Xiaowei Chen
    • Xiaofeng Liu
    • Hua Zhao

    Original Paper 18 January 2024 Pages: 867 - 878

    

11. Long-term medication for ADHD (LMA) trial: 2-year prospective observational study in children and adolescents. Core symptoms, daily functioning, and comorbidity outcomes

    • M. Johnson
    • J. Åsberg Johnels
    • E. Billstedt

    Original Paper Open access 27 January 2024 Pages: 879 - 890

    

12. Effect of an adapted physical activity program on stress, anxiety, depression in patients with schizophrenia: study protocol of a randomized-controlled trial

    • Lucie Venet-Kelma
    • Yannick Morvan
    • Laurence Kern

    Original Paper 05 September 2023 Pages: 891 - 902

    

13. One-year efficacy of a lifestyle behavioural intervention on physical and mental health in people with severe mental disorders: results from a randomized controlled trial

    • M. Luciano
    • G. Sampogna
    • A. Fiorillo

    Original Paper Open access 04 September 2023 Pages: 903 - 915

14. A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia

    • Shimeng Dong
    • Johannes Schneider-Thoma
    • Stefan Leucht

    Original Paper Open access 01 August 2023 Pages: 917 - 928

    

15. Smartphone video games improve cognitive function in patients with chronic schizophrenia: a randomized controlled trial

    • Shengya Shi
    • Shu Cui
    • Kai Zhang

    Original Paper 18 August 2023 Pages: 929 - 939

    

16. Reward motivation adaptation in people with negative schizotypal features: development of a novel behavioural paradigm and identifying its neural correlates using resting-state functional connectivity analysis

    • Yong-jie Yan
    • Hui-xin Hu
    • Raymond C. K. Chan

    Original Paper 03 July 2023 Pages: 941 - 953

    

17. Emotional distress and dysregulation as treatment targets to reduce suicide in psychosis: a scoping review

    • Peter Phalen
    • David Kimhy
    • Melanie Bennett

    Invited Review 19 August 2023 Pages: 955 - 961

    

18. Targeting metacognitive change mechanisms in acute inpatients with psychotic symptoms: feasibility and acceptability of a modularized group intervention

    • Eva Gussmann
    • Christoph Lindner
    • Johannes Kopf-Beck

    Original Paper Open access 23 September 2023 Pages: 963 - 979

    

19. A systematic review of EEG neurofeedback in fibromyalgia to treat psychological variables, chronic pain and general health

    • Carlos Barbosa Torres
    • Eloísa Julia Guerrero Barona
    • Juan Manuel Moreno Manso

    Invited Review Open access 14 May 2023 Pages: 981 - 999

    

20. Transcranial direct current stimulation combined with a brief intervention for smoking cessation: a randomized double-blind clinical trial

    • Ulrich Palm
    • Mark Obergfell
    • Tobias Rüther

    Original Paper Open access 13 November 2023 Pages: 1001 - 1011

    

21. Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesions

    • Ana-Maria Iorgu
    • Andrei-Nicolae Vasilescu
    • Peter Gass

    Short Communication Open access 07 November 2023 Pages: 1013 - 1019

    

22. Correction: Different autism measures targeting different severity levels in children with autism spectrum disorder

    • Chien-Yu Huang
    • Kuan-Shu Chen
    • Kuan-Lin Chen

    Correction 28 October 2023 Pages: 1021 - 1021